MINNEAPOLIS--(BUSINESS WIRE)--Urologix®, Inc. (NASDAQ:ULGX), received approval on October 1, 2009 from The Nasdaq Stock Market to transfer the listing of its common stock from The Nasdaq Global Market to The Nasdaq Capital Market. This resolves the Notice of Deficiency announced on September 17, 2009. The Company’s common stock will continue to be traded under the symbol “ULGX” and trading of its common stock will be unaffected by this transfer. The transfer to The Nasdaq Capital Market will be effective as of the opening of business on October 5, 2009.
